These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 126005)

  • 1. Time-lapse changes in the concomitant immunity of lymphocytes from different sites of mice isografted with methylcholanthrene-induced tumor.
    Orita K; Ohnishi N; Matuso Y; Konaga E; Kokumai Y
    Acta Med Okayama; 1975 Apr; 29(2):85-91. PubMed ID: 126005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allogeneic inhibitory activity of regional lymph node cells in the mouse isografted with methylcholanthrene-induced tumor.
    Orita K; Onishi N; Kunisada K; Konaga E; Kokumai Y
    Acta Med Okayama; 1975 Jun; 29(3):183-7. PubMed ID: 127512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage migration inhibition-activity after implantation of methylcholanthrene-induced sarcoma, Ehrlich ascites cancer or mouse ascites hepatoma-134 cancer cells in mice.
    Yumura M
    Acta Med Okayama; 1976 Feb; 30(1):37-48. PubMed ID: 184687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor activity of astaxanthin and its mode of action.
    Jyonouchi H; Sun S; Iijima K; Gross MD
    Nutr Cancer; 2000; 36(1):59-65. PubMed ID: 10798217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-specific immune responsiveness of the tumor-bearing host.
    Burk MW; Yu S; McKhann CF
    Isr J Med Sci; 1976; 12(4-5):360-8. PubMed ID: 939694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Augmentation of the anti-tumor activity of regional lymph node lymphocytes and spleen cells of tumor-bearing mice by culture with T cell growth factor in vitro--a comparison of the intestinal cancer model and footpad cancer model].
    Hori T; Kan N; Inamoto T; Nio Y; Ohgaki K; Kodama H; Tobe T
    Nihon Geka Gakkai Zasshi; 1986 Mar; 87(3):287-96. PubMed ID: 3487027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of suppressor cells by syngeneic tumor transplants in mice.
    Argyris BF
    Cancer Res; 1978 May; 38(5):1269-73. PubMed ID: 147732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antitumor activity of the lymphocytes of BALB/c and C57BL mice during methylcholanthrene carcinogenesis].
    Umanskiĭ IuA; Semenova-Kobzar' RA; Kushko LIa; Tovmachenko NN
    Vopr Onkol; 1976; 22(6):40-4. PubMed ID: 969342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro studies on the inhibitory effect of lymph-node cells. I. Antitumor activity of regional lymph-node cells from methylcholanthrene-induced sarcoma bearing mice on the same primary culture sarcoma cells.
    Osugi M
    Acta Med Okayama (1952); 1970 Aug; 24(4):447-56. PubMed ID: 4254199
    [No Abstract]   [Full Text] [Related]  

  • 10. The activity of regional nodes in the evolution of immune responses to allogeneic and isogeneic tumors.
    Barna B; Deodhar SD
    Cancer Res; 1975 Apr; 35(4):920-6. PubMed ID: 1116149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of sera from tumor-bearing mice on mitogen and allogeneic cell stimulation of normal lymphoid cells.
    Whitney RB; Levy JG
    J Natl Cancer Inst; 1975 Mar; 54(3):733-41. PubMed ID: 123599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on T and B lymphocytes in rats bearing methylcholanthrene-induced tumor.
    Klobusická M; Kalafut F; Novotná L
    Neoplasma; 1978; 25(6):667-77. PubMed ID: 313020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of the splenic cells of tumor-bearing mice on the allograft immune response].
    Spasokukotskiĭ AL
    Vopr Onkol; 1985; 31(7):87-91. PubMed ID: 4024565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in the host lymphocyte subsets during chemical carcinogenesis.
    Brodt P; Lala PK
    Cancer Res; 1983 Sep; 43(9):4315-22. PubMed ID: 6871866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in cellular components of spleen and lymph node cells and the effector cells responsible for Meth A tumor eradication induced by zinostatin stimalamer.
    Masuda E; Maeda H
    Cancer Res; 1996 Apr; 56(8):1868-73. PubMed ID: 8620506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction in culture between mouse ascites hepatoma (MH-134) cells and lymphoid cells of isologous mice.
    Katsuta H; Ashikawa K; Takaoka T
    Jpn J Exp Med; 1975 Aug; 45(4):269-84. PubMed ID: 171464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time-lapse changes in the concomitant immunity of lymphoid cells from different regions of Ehrlich tumor-bearing mice and alterations in blastformation rate by PHA-stimulation.
    Orita K; Tomoyasu S; Kaneda S; Miwa H; Konaga E
    Acta Med Okayama (1952); 1972 Aug; 26(3):81-8. PubMed ID: 4268711
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on lymphatic metastasis. I. Primary immunoregulatory role of regional lymph nodes in the establishment of lymphatic metastases.
    Yoshida K; Tachibana T
    J Natl Cancer Inst; 1985 Dec; 75(6):1049-58. PubMed ID: 2866267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics and in vivo homing of long-term T-cell lines and clones derived from tumor-draining lymph nodes.
    Matsumura T; Sussman JJ; Krinock RA; Chang AE; Shu S
    Cancer Res; 1994 May; 54(10):2744-50. PubMed ID: 8168105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of cell-mediated cytotoxicity against tumor-associated antigens by suppressor lymph node cells from mice bearing methylcholanthrene-induced sarcomas.
    Indrová M; Bubeník J
    Neoplasma; 1979; 26(4):405-12. PubMed ID: 160510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.